Skip to main content

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
URMC / News / Top Cardiologist Will Give Keynote Address at Annual Hoffman Day

Top Cardiologist Will Give Keynote Address at Annual Hoffman Day

Monday, April 14, 2008

Eugene Braunwald, M.D., the Distinguished Hersey Professor of Medicine at Harvard Medical School and chairman of Thrombolysis in Myocardial Infarction (TIMI) Study Group at the Brigham and Women’s Hospital, will speak Monday, April 28, at the University of Rochester School of Medicine and Dentistry’s annual Marvin J. Hoffman Day award ceremonies.
Braunwald is considered one of the premier cardiologists in the world. Most heart attack survivors have never heard of him, but chances are his research helped save their lives or improve their recovery, the Boston Globe once reported.
Braunwald served as the first chief of the cardiology branch and as clinical director of the National Heart, Lung and Blood Institute. He was the founding chairman of the Department of Medicine at the University of California at San Diego. From 1972 to 1996 he was chairman of the Department of Medicine at the Brigham and Women's Hospital. He was a founding trustee and chief academic officer of Partners HealthCare System, created by the Brigham and Women’s and Massachusetts General hospitals.
Science Watch listed Braunwald as the most frequently cited author in cardiology. He is an editor of Harrison's Principles of Internal Medicine, and the founding editor of Heart Disease, now in its eighth edition, the most influential textbooks in their fields. He was the first cardiologist elected to the National Academy of Sciences of the United States.
For the past 24 years, as chairman of the TIMI Study Group, he and his colleagues have demonstrated improved patient survival with a patent coronary artery which led to the widely accepted “open artery hypotheses.” They were the first to show the benefit of preventing adverse remodeling of the infarcted ventricle with angiotensin converting enzyme (ACE) inhibition. In the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE-IT) 2 Trial, in 2004, they demonstrated the benefit of more intensive reduction of low-density lipoprotein in high risk coronary artery patients, which has already changed practice guidelines and will favorably affect the lives of millions.
The Hoffman Day ceremony will be held in the Class of 1962 Auditorium in the Kornberg Medical Research Building of the Medical Center. The event begins at noon.
The Center for Advocacy, Community Health, Education and Diversity (CACHED) and the School of Medicine and Dentistry present the annual Marvin J. Hoffman Day. The event highlights medical student participation in community outreach, international medicine, basic science or clinical research and geriatric research. Awards are given for the best student project in each area and to faculty mentors.

Media Contact

Public Relations Department

(585) 275-3676

article hit counter